IDSA Home

What's New

Leadership and Funding Can Meet the Challenges of COVID-19: A Vaccine Strategy, Investments in Public Health Are Needed to Stop the Spread of the Virus

The Infectious Diseases Society of America and its HIV Medicine Association strongly support the incoming Administration’s request for $400 billion to strengthen our pandemic response and safely reopen schools.

Accelerated Vaccine Rollout Is Critical to Pandemic Control: Resources and Collaboration Will Be Essential to Success

Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

IDSA releases new recommendations on the use of baricitinib in hospitalized patients with COVID-19 and an updated literature review on hydroxychloroquine for the Treatment & Management of Patients with COVID-19

HIVMA Appoints Marwan Haddad, MD, MPH, as Chair-Elect

The HIV Medicine Association is pleased to announce the special appointment of Marwan Haddad, MD, MPH, as chair-elect. Dr. Haddad served on the HIVMA Board of Directors from October 2017 to October 2020 and is medical director of the Center for Key Populations for Community Health Center, Inc.

Address COVID-19 Vaccine Access Challenges with Leadership, Funding, Collaboration and Science

The current obstacles to swift and widespread COVID-19 vaccine access are impeding control of the pandemic amid soaring rates of infections, illnesses, hospitalizations and deaths and must be addressed effectively and immediately.

Learn from the ID Experts: Navigating the Revised CPT® Codes for Office and Outpatient E/M Services

Thursday January 14^th 5:00pm EST

Join Dr. Ron Devine, FIDSA and Dr. Prashant Malhotra, FIDSA as they discuss the changes and provide practical insight on how to use the revised codes and associated documentation using real-world ID specific clinical examples. Register Today

COVID-19 Diagnostic Guidelines Updates (Jan. 16, 2021)

1/16/2021

CDC/IDSA COVID-19 Clinician Call - Long COVID (with extended time for a Vaccine Q&A)

1/16/2021

IDSA Media Briefing: U.S. COVID Vaccine Rollout

1/14/2021

IDWeek 2020

Dr. Fauci Kicks Off IDWeek2020’s “Chasing the Sun” Event

Anthony Fauci, M.D., FIDSA, director of the National Institute of Allergy and Infectious Diseases, kicked off this year’s premier virtual infectious diseases conference with an overview of the public health and scientific challenges of COVID-19 in the United States. Login to this year’s program now.

The Voice of Truth About the Pandemic: Thank You Dr. Fauci

Renowned leaders, policy makers and medical experts offer their thanks to NIAID Director Anthony Fauci, M.D., FIDSA, as he kicks off IDWeek 2020 and the global Chasing the Sun event.

Science Speaks: Global ID News

COVID-19: Key points from S.Africa scientists regarding variant “501Y.V2” — not more severe, but convalescent sera may be less effectiveExternal Link

If dual infections occur with two SARS-CoV-2 viruses, will recombination result in more contagious or deadly variants?External Link

IDSA on Twitter

New in the Journals

A defense of the classical model of transmission of respiratory pathogensExternal Link

Reply to Meyerowitz and RichtermanExternal Link

Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for COVID-19 Convalescent PlasmaExternal Link

Meta-analysis of Clinical Outcomes Using Ceftazidime/Avibactam, Ceftolozane/ Tazobactam, and Meropenem/ Vaborbactam for the Treatment of Multidrug Resistant Gram-Negative InfectionsExternal Link

View All

Journals